Common Risk Factors for Atrial Fibrillation After Transcatheter Aortic Valve Implantation: A Systematic Review from 2009 to 2024 DOI Creative Commons

John Fernando Montenegro-Palacios,

Sinthia Vidal-Cañas,

Nelson Eduardo Murillo-Benítez

et al.

Journal of Cardiovascular Development and Disease, Journal Year: 2025, Volume and Issue: 12(3), P. 90 - 90

Published: Feb. 28, 2025

Transcatheter Aortic Valve Implantation (TAVI) is an effective treatment for severe aortic stenosis in high-risk patients; however, atrial fibrillation (AF) a common complication associated with the procedure. New-Onset Atrial Fibrillation (NOAF) after TAVI linked to increased mortality and additional complications. This study aimed evaluate incidence of NOAF following identify risk factors development thromboembolic events. A systematic review 18 studies was conducted using databases such as MEDLINE/PubMed, EMBASE, Web Science, Scopus, Cochrane Library, Google Scholar, Wiley Online SciELO, Redalyc. No language restrictions were applied, search covered from 2009 2024. The follow-up period ranged 48 h 730 days, mean 180 days. Early monitoring management AF are essential patients undergoing TAVI. up 29.04%, meaning about 29 out every 100 affected. rates varied between 7.2% 37%, average around 20. Standardizing anticoagulation strategies important reduce Randomized needed relationship post-TAVI determine whether marker higher or independent factor these patients.

Language: Английский

Common Risk Factors for Atrial Fibrillation After Transcatheter Aortic Valve Implantation: A Systematic Review from 2009 to 2024 DOI Creative Commons

John Fernando Montenegro-Palacios,

Sinthia Vidal-Cañas,

Nelson Eduardo Murillo-Benítez

et al.

Journal of Cardiovascular Development and Disease, Journal Year: 2025, Volume and Issue: 12(3), P. 90 - 90

Published: Feb. 28, 2025

Transcatheter Aortic Valve Implantation (TAVI) is an effective treatment for severe aortic stenosis in high-risk patients; however, atrial fibrillation (AF) a common complication associated with the procedure. New-Onset Atrial Fibrillation (NOAF) after TAVI linked to increased mortality and additional complications. This study aimed evaluate incidence of NOAF following identify risk factors development thromboembolic events. A systematic review 18 studies was conducted using databases such as MEDLINE/PubMed, EMBASE, Web Science, Scopus, Cochrane Library, Google Scholar, Wiley Online SciELO, Redalyc. No language restrictions were applied, search covered from 2009 2024. The follow-up period ranged 48 h 730 days, mean 180 days. Early monitoring management AF are essential patients undergoing TAVI. up 29.04%, meaning about 29 out every 100 affected. rates varied between 7.2% 37%, average around 20. Standardizing anticoagulation strategies important reduce Randomized needed relationship post-TAVI determine whether marker higher or independent factor these patients.

Language: Английский

Citations

0